Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT05544019

Conditions: ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations: Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States

Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States

Napa Research Pompano Beach, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 36 locations

View Trial Details

Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

NCT05079282

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

University of California Irvine Medical Center - Chao Family Comprehensive Cancer Center Orange, California, United States

Stanford Cancer Institute Palo Alto, California, United States

View all 20 locations

View Trial Details

Recruiting

Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)

NCT06517511

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

NCT06710418

Conditions: Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, +25 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

NCT07206121

Conditions: Breast Cancer, Breast Cancer - Infiltrating Ductal Carcinoma, Breast Diseases, +17 more
Locations: University of Texas Medical Branch at Galveston, TX Galveston, Texas, United States

View Trial Details

Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

NCT06393738

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Clinical Trial Site New Haven, Connecticut, United States

Clinical Trial Site Detroit, Michigan, United States

Clinical Trial Site New Brunswick, New Jersey, United States

Clinical Trial Site New York, United States

View all 17 locations

View Trial Details

Recruiting

Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

NCT04848064

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma

NCT07398963

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

NCT06484920

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations: Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States

View Trial Details

Recruiting

The PRE-VAIL Study

NCT07176624

Conditions: ARDS (Moderate or Severe), Enteral Nutrition Feeding, Hemic and Lymphatic Diseases, +11 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions